Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)

11.60 -0.22 (-1.86%) At close: 03:00PM CST

Hainan Huluwa Pharmaceutical Group Co., Ltd.

No. 8, Yaogu 4th Road
Phase II, Yaogu Industrial Park Haikou National High-tech Zone
Haikou 570311
China
86 898 6868 9766
https://www.huluwayaoye.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2,468

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Jinping Liu	General Manager & Chairman of the Board	N/A	N/A	1970
Mr. Tianbao Wei	Deputy General Manager	N/A	N/A	1967

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.

Corporate governance

Hainan Huluwa Pharmaceutical Group Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.